Research study Program year 2023 Source: CMS Open Payments

Composur, A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder

Research payments

$910,681

349 payments

Through program year 2023, $910,681 in research payments was reported against Composur, A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder, across 349 payments.

Paid by (largest first): Urovant Sciences Inc; Sumitomo Pharma America, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$209,837	98
2022	Research	$700,844	251

Breakdown

Who paid Research payments · program years 2022–2023

Urovant Sciences Inc $700,844 251 payments
Sumitomo Pharma America, Inc. $209,837 98 payments

Who received the money Research payments · program years 2022–2023

Medicus Alliance Clinical Research Org. Inc. Organisation paid for research $63,262 25 payments
Regional Research Specialists LLC Organisation paid for research $59,589 13 payments
Urology Centers Of Alabama Organisation paid for research $58,952 11 payments
Advanced Research INC Organisation paid for research $48,659 12 payments
University of Kansas Medical Center Research Institute, Inc. Organisation paid for research $37,345 10 payments
Accumed Research Associates Organisation paid for research $37,278 14 payments
University of Cincinnati Organisation paid for research $30,935 6 payments
Elligo Health Research Inc. Organisation paid for research $30,750 8 payments
Trihealth INC Organisation paid for research $25,546 17 payments
Carolina Medical Trials, LLC Organisation paid for research $25,110 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.